1. Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial. Issue 9 (September 2019) Authors: Cadavid, Diego; Mellion, Michelle; Hupperts, Raymond; Edwards, Keith R; Calabresi, Peter A; Drulović, Jelena; Giovannoni, Gavin; Hartung, Hans-Peter; Arnold, Douglas L; Fisher, Elizabeth; Rudick, Richard; Mi, Sha; Chai, Yi; Li, Jie; Zhang, Yiwei; Cheng, Wenting; Xu, Lei; Zhu, Bing; Green, Susan M... Journal: Lancet neurology Issue: Volume 18:Issue 9(2019) Page Start: 845 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗